))
Rational Management of Hospitalized Patients with Hyponatremia: Focus on Critically Ill Patients (Part 2 of 3)
Archived series ("HTTP Redirect" status)
Replaced by: www.ashp.org
When?
This feed was archived on July 23, 2018 02:23 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 126006673 series 172635
Content provided by ASHP Advantage. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ASHP Advantage or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Joseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about managing hyponatremia in critically ill patients, especially factors affecting the rate of serum sodium correction. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting.
Faculty:
Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair
Professor Emeritus
The Ohio State University College of Pharmacy
Adjunct Professor
The University of Texas College of Pharmacy
Austin, Texas
Amy L. Dzierba, Pharm.D., BCPS, FCCM
Clinical Pharmacist, Adult Critical Care
New York-Presbyterian Hospital
Lecturer
Columbia University School of Nursing
New York, New York
Jodie L. Pepin, Pharm.D.
Director of Pharmacy
Seton Medical Center Williamson
Seton Healthcare Family
Clinical Assistant Professor of Health Outcomes and Pharmacy Practice
The University of Texas College of Pharmacy
Austin, Texas
C.E. Credits: This activity is not eligible for continuing education credits.
30 episodes
Share
